TCL-1 is expressed in 90% of BPDCN cases and only 17% of c-AML, and it is also seen in a broad variety of B cell lymphoproliferative disorders and some T-cell disorders but is absent in NK cell lineages [19]. This evidence concerns the gene TCL1A and CD4+/CD56+ hematodermic neoplasm.